MUNARI, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 2.691
AS - Asia 1.997
EU - Europa 788
SA - Sud America 681
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 6.212
Nazione #
US - Stati Uniti d'America 2.635
SG - Singapore 785
BR - Brasile 575
CN - Cina 382
HK - Hong Kong 345
VN - Vietnam 209
UA - Ucraina 131
DE - Germania 112
FR - Francia 98
TR - Turchia 88
FI - Finlandia 87
IE - Irlanda 85
RU - Federazione Russa 85
GB - Regno Unito 68
AR - Argentina 50
IT - Italia 46
BD - Bangladesh 39
IN - India 33
ID - Indonesia 22
CA - Canada 21
ZA - Sudafrica 19
MX - Messico 18
IQ - Iraq 17
BE - Belgio 15
CO - Colombia 12
PK - Pakistan 12
SA - Arabia Saudita 11
UZ - Uzbekistan 11
EC - Ecuador 10
MA - Marocco 9
NL - Olanda 9
SE - Svezia 9
CL - Cile 8
JP - Giappone 8
PL - Polonia 8
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
JM - Giamaica 6
PY - Paraguay 6
TN - Tunisia 6
UY - Uruguay 6
AT - Austria 5
CZ - Repubblica Ceca 5
NP - Nepal 5
CH - Svizzera 4
EG - Egitto 4
JO - Giordania 4
PE - Perù 4
AL - Albania 3
CI - Costa d'Avorio 3
DZ - Algeria 3
ES - Italia 3
KE - Kenya 3
LB - Libano 3
MY - Malesia 3
PH - Filippine 3
RS - Serbia 3
AP - ???statistics.table.value.countryCode.AP??? 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
IR - Iran 2
LV - Lettonia 2
NI - Nicaragua 2
OM - Oman 2
SN - Senegal 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CR - Costa Rica 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
KZ - Kazakistan 1
LT - Lituania 1
MT - Malta 1
MU - Mauritius 1
PA - Panama 1
PS - Palestinian Territory 1
PW - Palau 1
SR - Suriname 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 6.212
Città #
Hong Kong 345
Singapore 336
Fairfield 320
The Dalles 251
Ashburn 200
Woodbridge 157
Princeton 140
Seattle 138
Wilmington 125
San Jose 121
Houston 110
Cambridge 103
Jacksonville 101
Beijing 98
New York 94
Helsinki 83
Istanbul 80
Lauterbourg 80
Dublin 79
Ho Chi Minh City 74
Ann Arbor 57
Hanoi 57
Los Angeles 51
São Paulo 41
Buffalo 35
Redondo Beach 34
San Diego 31
Council Bluffs 29
Des Moines 29
Moscow 28
Rio de Janeiro 23
Chicago 21
Shanghai 21
Chandler 18
Orem 18
London 17
Menlo Park 16
Brussels 15
Curitiba 13
Dallas 12
Belo Horizonte 11
Tashkent 11
Brasília 10
Dhaka 10
Frankfurt am Main 10
Munich 10
Nuremberg 9
Romola 9
Santa Clara 9
Buenos Aires 8
Campinas 8
Düsseldorf 8
Elk Grove Village 8
Haiphong 8
Johannesburg 8
Chennai 7
Contagem 7
Da Nang 7
Milan 7
Paris 7
San Francisco 7
Sorocaba 7
Warsaw 7
Guayaquil 6
Salt Lake City 6
Salvador 6
Tokyo 6
Amsterdam 5
Brno 5
Brooklyn 5
Chiswick 5
Hải Dương 5
Manaus 5
Manchester 5
Montevideo 5
Montreal 5
Norwalk 5
Poplar 5
Praia Grande 5
Recife 5
Stockholm 5
Thái Bình 5
Uberlândia 5
Wandsworth 5
Atlanta 4
Boston 4
Bắc Giang 4
Cairo 4
Denver 4
Dubai 4
Ha Long 4
Indaiatuba 4
Jeddah 4
Joinville 4
Karachi 4
Kingston 4
Lima 4
Mauá 4
Pretoria 4
Santo André 4
Totale 3.967
Nome #
Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma 123
Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors 117
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma 109
Prevalence of PD-L1 expression in head and neck squamous precancerous lesions: a systematic review and meta-analysis 107
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 105
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge 101
Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions 99
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis 95
ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case 94
An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine 92
Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma 91
⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer 91
Correction: Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma 89
Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma 89
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 89
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression 89
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 88
ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder 87
PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263 87
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 87
Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples 86
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 86
Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: a tissue microarray study of 149 patients treated by transurethral resection 85
NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines 84
Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases 79
Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker 78
Human Innate Lymphoid Cells: Their Functional and Cellular Interactions in Decidua 78
Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma 78
Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma 77
Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases 77
Concurrent targeting of potential cancer stem cells regulating pathways sensitizes lung adenocarcinoma to standard chemotherapy 77
Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms 76
PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory developed test using clone E1L3N in comparison with 22C3 and SP263 assays 75
Assessment of HER2 protein overexpression and gene amplification in renal collecting duct carcinoma: Therapeutic implication 75
Artificial intelligence applications for pre-implantation kidney biopsy pathology practice: a systematic review 74
The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases 74
Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies 73
PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability 73
MicroRNA expression profiling of Xp11 renal cell carcinoma 73
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 71
PD-L1 expression heterogeneity in non-small cell lung cancer: defining criteria for harmonization between biopsies and whole sections 71
High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins 71
Characterization of human NK cell-derived exosomes: Role of DNAM1 receptor in exosome-mediated cytotoxicity against tumor 71
Non-small cell lung cancer: land of conquest for immunotherapy 70
Human papillomavirus infection and immunohistochemical p16(INK4a) expression as predictors of outcome in penile squamous cell carcinomas 70
Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomy 70
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine 69
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 69
“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy 69
Artificial intelligence-based tools applied to pathological diagnosis of microbiological diseases 69
Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification 68
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes 67
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua 67
Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated With Penile Cancer Progression 64
Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8+ Tumor-Infiltrating Lymphocytes in Non-Small Cell Lung Cancer 64
Cathepsin k: A novel diagnostic and predictive biomarker for renal tumors 64
Artificial intelligence in head and neck cancer diagnosis 63
Strong association of insulin-like growth factor 1 receptor expression with histologic grade, subtype, and HPV status in penile squamous cell carcinomas: a tissue microarray study of 112 cases 63
PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs: An Interclone Evaluation by Differently Trained Pathologists 62
Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes? 62
Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma 61
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation 60
TCL1A expression in marginal zone lymphoma: a clinico-pathological evaluation in paired spleen and bone marrow samples 60
Challenges facing pathologists evaluating PD-L1 in head & neck squamous cell carcinoma 59
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems 58
Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome 58
Evaluation of S-phase fraction as a prognostic marker in mantle cell lymphoma 57
PD-1/pd-l1 in cancer: Pathophysiological, diagnostic and therapeutic aspects 56
Different effects of NK cells and NK-derived soluble factors on cell lines derived from primary or metastatic pancreatic cancers 55
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study 55
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 54
Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology 53
The immune checkpoint PD-1 in natural killer cells: Expression, function and targeting in tumour immunotherapy 53
Exploiting Human NK Cells in Tumor Therapy 51
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines 49
Wilms’ tumor primary cells display potent immunoregulatory properties on nk cells and macrophages 49
Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD-1 receptor 49
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 48
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 47
PD-L1 evaluation in head and neck squamous cell carcinoma: Insights regarding specimens, heterogeneity and therapy 47
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 44
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells 43
Pediatric tumors-mediated inhibitory effect on nk cells: The case of neuroblastoma and Wilms’ tumors 43
Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28 41
Program death ligand-1 immunocytochemistry in lung cancer cytological samples: A systematic review 40
Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity 40
PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation 39
Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword? 37
Technical and Diagnostic Issues in Whole Slide Imaging Published Validation Studies 36
Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma 32
Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects 14
Totale 6.309
Categoria #
all - tutte 46.199
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.199


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021305 0 0 0 0 0 0 0 0 0 159 50 96
2021/2022398 9 44 11 41 4 7 9 56 84 29 34 70
2022/2023263 81 0 6 2 5 89 6 17 32 2 13 10
2023/2024539 17 14 12 96 14 70 11 27 181 2 4 91
2024/20251.240 4 9 11 118 127 84 132 31 163 175 244 142
2025/20262.610 227 421 305 532 182 90 301 113 250 189 0 0
Totale 6.309